European Case Law Identifier: | ECLI:EP:BA:2018:T096914.20180605 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 05 June 2018 | ||||||||
Case number: | T 0969/14 | ||||||||
Application number: | 07110708.0 | ||||||||
IPC class: | A61K 9/72 A61K 9/14 |
||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | Pharmaceutical formulations for dry powder inhalers | ||||||||
Applicant name: | Vectura Limited | ||||||||
Opponent name: | Norton Healthcare Ltd | ||||||||
Board: | 3.3.07 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: |
|
||||||||
Keywords: | Transfer of partial priority (yes) Main request and auxiliary requests 1-3 - Validity of the priority (no) Main request and auxiliary requests 1-3 - Novelty under Article 54(3) EPC (no) Auxiliary request 4 - Admission into the proceedings (no) |
||||||||
Catchwords: |
Cf. points 1.2 and 1.3 |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t140969eu1.html
Date retrieved: 17 May 2021